At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top New York based CFO’ operating in the Medical space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Thomas Antonio
Vice President of Financial & CFO of Drive Medical
Thomas Antonio joined the Company in February 2004, and is primarily responsible for financial reporting. From 1986 through 1997, Thomas Antonio served as the Assistant Vice President and Controller of Charan Industries, a privately-held company which owned and operated bowling centers throughout the United States. From 1997 through February 2004, Thomas served as the Chief Financial Officer of several privately-held companies located in the metropolitan New York area.
Follow Thomas Antonio:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Neil Edwards
Chief Financial Officer of Vesselon
Neil Edwards is the CEO of Cellufun. Edwards served as the founding CEO of dotMobi, a mobile web services company, where he grew the company from a start-up to a multi-million dollar organization. At dotMobi he built a global customer base with multiple channel platforms and content partners that generated significant recurring revenue streams. Additionally,Mr. Edwards was instrumental in building a consortium of leading mobile brands including Nokia, Vodafone, Google, Telefonica, Telecom Italia, T-Mobile, Orascom, Microsoft, Visa and many others. Prior to dotMobi, he was instrumental in the growth of VeriSign and infoUSA,having served in senior leadership positions within both organizations.
Follow Neil Edwards:
About Forbes, Vesselon: Vesselon is a medical device company developing novel therapeutic Immuno-Oncology complexes.
Thomas Altier
CFO of Phreesia
Tom brings over 30 years of financial management experience to the chief financial officer role, including a “Big Four” career foundation and experience with several venture-backed, emerging-growth and SaaS businesses. As CFO of Phreesia, Tom is responsible for budgeting, forecasting, monthly reporting, financial analysis and internal controls. Prior to joining Phreesia, Tom was CFO at Perceptive Pixel, a developer of high-end, multi-touch display screens and related software, which was acquired by Microsoft in 2012. Tom is a CPA, and holds a BA and MBA from Columbia University.
Follow Thomas Altier:
About Phreesia: Phreesia automates the patient check-in process by collecting personal health information on the PhreesiaPad.
Gillian Munson
Chief Financial Officer of Iora Health
Follow Gillian Munson:
About Iora Health: Iora Health is a healthcare company that helps patients manage their health and navigate the healthcare system.
Jaime Bartushak
CFO of Citius Pharmaceuticals
Follow Jaime Bartushak:
About Citius Pharmaceuticals: Citius Pharmaceuticals is a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products.
Ethan Einwohner
Chief Financial Officer of Specified Testing Labs
I Ethan Einwohner formed Specified Testing Labs, LLC, a roll-up of environmental testing laboratories, in August 2013. Under Specified, Ethan led the acquisitions of the testing lab assets of: International Hydronics Corporation (Oct 2013); New Jersey Analytical Labs (Nov, 2013), CNA Environmental (Dec 2013); and Smith Environmental Labs (Apr 2014). At Specified, Ethan manages all financial aspects of the firm and has responsibilities for its acquisition and integration activities. With his laboratory operations team, Ethan forms and executes company strategy .
Follow Ethan Einwohner:
About CNA Environmental, Recurrent Capital Bridge Fund, Specified Testing Labs: Specified Testing Laboratories, LLC is a holding company of testing laboratories and related operating companies. Formed in September .
Douglas Larson
Group Chief Financial Officer of Beyond Air
Douglas Larson is the Group Chief Financial Officer at Beyond Air.
Follow Douglas Larson:
About Beyond Air: Beyond Air is a biotechnology company focused on the development of drugs for the treatment of lung infections.
Peter Collum
Chief Financial Officer and Chief Business Officer of Pharnext
More than 17 years’ experience in healthcare investment banking focused on M&A, financing and business development transactions. Previously partner at MTS Health Partners for public and private life sciences companies both in the US and abroad, and worked in the healthcare investment banking group at Bank of America. Started at Roche as an engineer.
Follow Peter Collum:
About Pharnext: Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.
David Cordo
CFO of Metamark Genetics
Mr. Cordo began his career in the life sciences industry in 1990. He held senior management positions in finance at Biogen Idec during his seven-year tenure where he put in place the financial infrastructure for the worldwide commercial launch of Avonex. For seven years, he was the Treasurer of Millennium Pharmaceuticals. At Millennium, he led finance teams in the raising of an $800 million follow-on equity offering and a $400 million convertible debt offering. He also led finance teams for three acquisitions. Dave has been interim chief financial officer for several venture capital backed life science companies, including Dicerna Pharmaceuticals, Epizyme, Inc., Link Medicine Corporation, TransForm Pharmaceuticals, Avila Therapeutics and Alinea Pharmaceuticals, and consulting on strategic financial issues for public and private life science companies. He is a Certified Public Accountant and holds an M.B.A. degree from Nichols College and a B.S.B.A. degree from Stonehill College. He is an active member of the Executive Committee of the Wake Forest University Parents’ Council and consults for several charitable organizations.
Follow David Cordo:
About Metamark Genetics, Novartis, Potenza Therapeutics, Semma Therapeutics: Metamark Genetics develops prognostic and predictive diagnostic tests that enable personalized treatment planning for cancer patients.
Matthew Stack
Chief Financial Officer of Koning
Matt Stack is a founder of XLP Capital, the founding manager of the Lambda Prime Investment Incubator Fund, and the Chief Investment Officer of XLP’s technology activist fund, Devonshire Capital Fund I. He is an experienced early and seed stage investor in high tech hardware and analytics companies with over $200M in completed deals, and serves as a technology advisor to a variety of institutions and family offices overseeing and directing over $500M. Over the past decade, Matt has acquired and developed a collection of minority interests in companies across North America ranging from small university spin outs to mid-sized industrial technology companies. Matt serves as an advisor to a number of privately held companies, where he manages and supervises technology and high performance computing investments. Matt has served as the Director of Computational Science at Mars Corporation and as a Partner at 3LP – a Boston-based elite Intellectual Property advisory firm. Matt’s prior experiences include managing acquisitions for a $120M corporate-led technology buyout fund in Palo Alto, as well as spending 6 years at The Boston Consulting Group in the Boston and New York offices, where he worked on projects in the Health Care, IT, Retail, Industrial Goods, and Strategy practice areas. He frequently helped corporate clients with topics including corporate growth strategy, merger and acquisitions, and post-merger integration. Before BCG, Matt co-founded and invested in a health care software startup, a small electronics company, an advanced composites design firm, and a semiconductor distribution company that traded high performance semiconductor chips between Shenzhen, Tokyo, and Tecate. Matt holds a B.S.E. in electrical engineering from Princeton University. He is a benefactor and sponsor of the TEDx conference series, and has sponsored research at the Santa Fe Institute in New Mexico, the Strategy Institute in New York, MIT’s Broad Institute, the Highlands Forum, the University of Oxford, and the Department of Defense. He is an accomplished computer hacker and cryptanalyst, and has written and advised on state-run network cyber-warfare policy, and agility-based strategic combat. Matt was recognized in 2009 by Hackaday as one of the top 10 most influential hardware hackers, and has been featured in Wired Magazine and the Wall Street Journal for his hobby electronics projects. He is the author of 11 neuroscience patents covering devices, analytical methods, and algorithms for detecting concussion and improving cognitive performance. In his spare time, he has been an Olympic hopeful in javelin, a competitive speedskater, a motorcycle collector, and is currently a professional windsurfer.
Follow Matthew Stack:
About Koning, XLP Capital: 3D Breast CT, Breast Cancer detection, Breast cancer diagnostics
Steven Paladino
EVP & CFO of Henry Schein, Inc
Follow Steven Paladino:
About Henry Schein, Inc: Henry Schein, Inc. is the world’s largest provider of health care products and services to office-based dental, medical and animal health
Asad Sajwani
CFO of VirTrial
Asad Sajwani is the Chief Financial Officer at VirTrial.
Follow Asad Sajwani:
About VirTrial: Virtrial is a technology company using a stable, long-standing telehealth platform to transform the clinical trial industry.
Tomer Benami
Chief Financial Officer of VirtualHealth
Follow Tomer Benami:
About KPMG International Limited, VirtualHealth: The only care management platform purpose-built for value-based care. Our vision is proactive healthcare for all.
O. James Sterling
Chief Financial Officer of Renalytix AI
Follow O. James Sterling:
About Renalytix AI: RenalytixAI is a developer of artificial intelligence (AI) enabled clinical diagnostic solutions for kidney disease.
Isaac Miller
CFO, Co-Founder of Cresilon, Inc.
Isaac co-founded Suneris and is responsible for all financial operations. He directs Suneris’ business initiatives and manages investor relations. Through financial analysis and forecasting, Isaac devises and implements strategic financial plans that maximize assets and foster growth at Suneris. Currently, he is an Innovation Consultant at NYU Polytechnic School of Engineering. Isaac holds a BS in Finance and Management from NYU Stern School of Business.
Follow Isaac Miller:
About Cresilon, Inc.: Cresilon is a medical device company that produces and markets solutions for trauma care.
Puneet Sapra
Chief Financial Officer of StayWell Company
Follow Puneet Sapra:
About Frontida Biopharm, MBX Capital, StayWell Company: StayWell is a health engagement company that helps its clients engage and educate people to improve health and business results.
Laura Schulhof
CFO of Ambra Health
Laura drives the financial and accounting, legal and HR functions of Ambra Health with a strong background in strategic finance. Prior to joining Ambra in January 2017, Laura was Chief of Staff of the CEO at Endurance International, a publicly-traded SaaS hosting and IT services business for SMBs. While there, she worked closely with the functional leaders of each department and focused finance and operations for the company’s growth ventures. She also worked closely with the BD, Finance and Legal teams to complete the acquisition of Constant Contact in 2015. Prior to joining Endurance in 2015, Laura was an investment banker for Credit Suisse in the Technology group based in San Francisco. While there, Laura was a part of many IPOs, equity and debt financings (including of EIGI) and M&A transactions on both the buy and sell side. Laura is a graduate of Princeton University.
Follow Laura Schulhof:
About Ambra Health: Ambra Health is a medical data and image management SaaS provider company.
Benjamin Newmark
President & CFO of SolasCure
Benjamin Newmark is the Founder, President, and CFO at SolasCure.
Follow Benjamin Newmark:
About Better.com, SolasCure: Solascure is a biotechnology company focused on the development of fit for purpose, efficacious wound care products.
Alan A. Bucher,
Chief Financial Officer of Getinge
Alan A. Bucher is the Chief Financial Officer at Getinge.
Follow Alan A. Bucher,:
About Getinge: Getinge identifies customer issues and promotes clinical and economic benefits and follow and support the customer decision process.
Chris Dorsey
CFO and COO of Getinge
Chris Dorsey is the CFO and COO at Getinge.
Follow Chris Dorsey:
About Getinge: Getinge identifies customer issues and promotes clinical and economic benefits and follow and support the customer decision process.
Matt Kapusta
Chief Financial Officer of UniQure
Matt Kapusta joined uniQure as CFO in January 2015 with nearly 20 years of experience in the life sciences industry. Most recently, Matt was Senior Vice President at AngioDynamics responsible for corporate development, strategic planning and national accounts. Prior to AngioDynamics, he served as Vice President, Finance for Smith & Nephew Orthopaedics. Matt’s career also includes more than a decade of investment banking experience focused on emerging life sciences companies. Matt was Managing Director, Healthcare Investment Banking at Collins Stewart, and held various positions at Wells Fargo Securities, Robertson Stephens and PaineWebber. Matt holds a Master of Business Administration from New York University’s Stern School of Business, a Bachelor of Business Administration from University of Michigan’s Ross School of Business and earned his Certified Public Accountant license in 1996 while at Ernst & Young.
Follow Matt Kapusta:
About UniQure: uniQure is focused on the research and early development of human gene-based therapies.
Thomas Finn
Chief Financial Officer of Owlstone
Mr. Finn has over 25 years of experience in accounting, audit and finance. He has held several senior or advisory positions for IBM Corporation, Purdue Pharma and for various start-up companies where he has always focused on improving processes, controls and procedures. Mr. Finn holds a Bachelor of Business Administration in Finance & Economics from the University of Massachusetts at Amherst and a Masters of Business Administration in International Business from Aalto University (formerly Helsinki School of Economics) in Helsinki, Finland. Mr. Finn has worked with Owlstone in various capacities since May 2005 and is responsible for implementing and overseeing the financial functions of the company.
Follow Thomas Finn:
About Owlstone, Owlstone Nanotech: Owlstone develops, manufactures and supplies chemical detection solutions across a wide range of markets and applications.